Med

US-based InsightRX’s Precision Medication Dosing Tool Closes $10M US Dollars

Integrated medication dosing platform InsightRX has closed a $10 million Series A funding round headed by HealthX Ventures. Other participants in the round included Rock Health, OSF Healthcare, Leawood Venture Capital and Premier Inc., as well as returning backer GreatPoint Ventures. According to the announcement, this brings the company’s total backing to $13 million. The proceed will be used to enhance the capability of supply chain and pharmaceutical market.

The two main software platform are InsightRX Nova and InsightRX Apollo have already approved and applied in plenty of medical care center and life science companies in US. InsightRX Nova, based on EHR data to develop individualized medication dosing regiments, physicians can employ the tool at the bedside to assist with treatments for more than 100 drug-assisted therapeutic areas. While Nova’s regimens are designed to be improved over time via artificial intelligence examining real-world clinical data, the company also offers an aggregated analytics platform called InsightRX Apollo that aims to help organizations identify larger trends in treatment responses, such as yet-unreported toxicity or efficacy.

In medical care field, personalization comes as a more and more important concern. For example, Cathay General Hospital in Taiwan has started to build up a system, digital individualized medication dosing system, to lessen heath takers’ burden. The system can shorten the dosing time and it meanwhile saves up 80% time. The next move of Cathay General Hospital will strengthen the current medical care system capability, also, aims to extend to the further the elderly health care area so as to foster a precise individualized medication service.

Source:https://bit.ly/2kOIUK7

美國InsightRX獲得1,000萬美元的A輪融資,由HealthX Ventures領投,Rock Health、OSF Healthcare、Leawood Venture Capital、Premier Inc.,以及之前的投資者GreatPoint Ventures都參與了這次的融資,總募集資金達1,300萬美元。本輪資金將用於拓展新的治療領域以及提升平臺的效能,進一步強化在供應鏈與製藥市場的影響力。

InsightRX旗下兩款產品InsightRX Nova以及InsightRX Apollo在歐美已經獲得百家照護機構與生命科學公司的採用,InsightRX Nova是一個連結電子健康紀錄(EHR)的個人化用藥平臺,醫師可以利用這個平臺針對超過100種藥物進行個人化的床邊用藥治療;InsightRX Apollo則是結合AI協助提供臨床藥物的醫學資料分析,協助醫院和護理團隊瞭解整體藥物的治療反應,可以加以改善並發現藥物可能產生的其他療效或毒性。

個人化醫療儼然成為趨勢,像是國泰醫院2013年也開發導入的「行動智慧化療給藥作業管理系統」,取代過去護理人員的雙人核對機制,讓化療給藥更快速、精准,不僅提升病人用藥安全,更縮短護理師8成的備藥及給藥時間。國泰醫院也規劃配備多功能的「智慧床邊終端系統」,期望未來從現有的在院診療服務,延伸至到院前及出院後的遠距照護,提供更精准的個人化醫護服務。

資料來源:https://bit.ly/2kOIUK7


Source link
Tags
Back to top button
close
Thanks !

Thanks for sharing this, you are awesome !

Pin It on Pinterest

Share This

Share this post with your friends!

Close